This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Harvard College. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: The Innovations of Inventor Chong Si
Introduction
Chong Si is an accomplished inventor based in Allston, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on cortistatin analogues. With a total of 3 patents to his name, Chong Si continues to push the boundaries of scientific research and development.
Latest Patents
Chong Si's latest patents focus on cortistatin analogues and their syntheses. These inventions relate to analogs of cortistatin A, J, K, and L, which have specific chemical formulas and salts. The patents detail processes for preparing these compounds and their intermediates, as well as pharmaceutical compositions that include these compounds. Furthermore, they outline methods for treating proliferative diseases, diseases associated with aberrant angiogenesis, and methods for inhibiting angiogenesis. The comprehensive nature of these patents highlights Chong Si's dedication to advancing medical science.
Career Highlights
Chong Si is affiliated with Harvard College, where he conducts his research and development. His work has garnered attention in the scientific community, showcasing his expertise and innovative spirit. His contributions are not only valuable to academia but also have the potential to impact the pharmaceutical industry significantly.
Collaborations
Chong Si collaborates with notable colleagues, including Cristina Montserrat Nieto-Oberhuber and Matthew D Shair. These partnerships enhance the quality and scope of his research, fostering an environment of innovation and discovery.
Conclusion
Chong Si is a prominent inventor whose work on cortistatin analogues has the potential to revolutionize treatments for various diseases. His dedication to research and collaboration with esteemed colleagues at Harvard College underscores his commitment to advancing medical science.